13 BlueBirds in orbit, 60+ MNO partnerships (3B+ subs), $1.3B backlog, FY26 revenue guide $150-200M (vs $5M in FY25) — the deployment is real. But $22.2B market cap on ~$175M FY26E revenue = ~127x fw EV/Rev; $2.96B long-term debt + $1.15B July 2026 convertible notes signal continuing capital intensity ($350-425M/qtr capex). Class action overhang (Pomerantz, filed), Starlink D2D competitive escalation, and consistent dilution events (−17% on July conv notes) are the three asymmetric risks. Stock −57% from 52W high $133.86 to $56.93 but still 10x FY25 revenue multiples on peers like Iridium.
Primary FV = $52 base case derived from FY27E revenue × 15x fw EV/Rev (base), with explicit option-value additions for J-LEO + US JV and quantitative deductions for debt, dilution and class action reserve. Implicit multiple at FV = 29x fw EV/Rev on FY27E $700M — well above peer median 5x but defensible given 60+ MNO scale advantage; this multiple is the dominant assumption . Cross-check (DCF with 15Y rev CAGR 25%): $48-62/sh, consistent. Sensitivity: ±2x fw multiple = ±$11/sh. Class action reserve $200M midpoint ($100-300M range typical for securities class actions of this size); larger settlements possible if lead plaintiff deadline brings major institutional holders. ⚠️ Not investment advice. Early-stage valuation with wide dispersion; position sizing should account for 50%+ scenario variance.
| Component | Assumption | USD/share |
|---|---|---|
| Core D2D commercial EV | FY28E revenue $1.5B × 15x fw EV/Rev (peer-adjusted: GSAT ~8x, RKLB ~15x, premium for D2D TAM & MNO breadth) = $22.5B EV / 389M sh | +57.84 |
| Pro forma cash (post-July conv) | $3.7B pro forma cash+restricted / 389M sh | +9.51 |
| Total debt bridge | Long-term debt $2.96B + $1.15B conv notes = $4.11B / 389M sh (negative to equity) | −10.57 |
| J-LEO Japan option | Up to $1B non-dilutive gov capital × 50% probability × 1.0x value multiplier / 389M sh | +1.29 |
| US JV (AT&T + Verizon) | Top-3 US carriers JV optionality: $5B platform value × 30% probability / 389M sh | +3.86 |
| Capex funding dilution reserve | Est. $2.5B additional capex 2027-28 funded 60% equity: $1.5B / avg price $70 = 21M new sh × $56 cost basis haircut / 389M sh | −3.02 |
| Class action litigation reserve | Mid-case settlement $100-300M (post-trial): $200M midpoint / 389M sh | −0.51 |
| Convertible dilution (conv notes) | $1.15B conv at implied ~$75 cap price = 15.3M new sh at full conv × dilution impact / 389M sh | −1.26 |
| Starlink D2D competitive haircut | Shared-market scenario: 20% of core EV ($22.5B) × 0.4 = $1.8B equity haircut / 389M sh — competitive risk not fully in 15x multiple | −5.14 |
| FV base case | Exact sum: 57.84 + 9.51 − 10.57 + 1.29 + 3.86 − 3.02 − 0.51 − 1.26 − 5.14 = $52.00 | ≈ $52.00 |
15.65% short interest is HIGH (threshold 15-25% = high) and reflects (a) valuation skepticism at ~120x fw rev, (b) dilution concern post-July conv raise, (c) hedging of convertible holders. Days to cover 3.41 is low — a short squeeze requires sustained buying pressure. Insider activity: multiple SBC vesting events but no large open-market insider buys to signal alignment. CEO Abel Avellan + co-founder/CFO ownership stays material through SPAC merger structure. No formal insider sales >$500K disclosed in recent Form 4 batch per public search; large shelf registration remains active (potential for ATM activity ahead of 2027 capex ramp).
| Item | FY2024 | FY2025 | FY2026E (mid) | FY2027E | Guidance 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 14 | 5 | 175 | ~700 | $150–$200M |
| Adj OpEx ($M) | 175 | 330 | 480 | ~550 | Q3: $105–$115M (ex-COGS) |
| Net loss attrib. ($M) | (170) | (220) | (850) | ~(650) | — (incl. $125.9M involuntary conversion loss Q2) |
| Capex ($M) | 250 | 890 | 1,600 | ~1,400 | Q3: $350–$425M; weighted H2 |
| Cash EOP ($M) | 400 | 650 | ~2,000 | ~400 (pre-raise) | Pro forma H1 = $3.7B |
| LT debt ($M) | 80 | 2,210 | 4,110 | ~5,000 | Post-July $1.15B conv notes 1.625% due 2034 |
| Backlog ($B) | N/A | 0.3 | 1.3 | ~2.5 | Commercial + Gov awards |
| Satellites in orbit | 1 (BW3) | 5 | 13 → 30-45 | ~45 | BB14-16 shipping, BB17-46 in production |
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 1.2 | 0.8 | 2.5 | 14.8 | 31.5 |
| Adj OpEx ($M) | 45 | 58 | 72 | 95 | 119 |
| Net loss ($M) | (60) | (70) | (95) | (170) | (231) |
| Cash EOP ($M) | 450 | 500 | 650 | 2,100 | 2,700 |
| Satellites in orbit | 1 | 5 | 5 | 10 | 13 |
Business model — Space-based cellular broadband direct to standard smartphones
Commercial MNO (D2D) ~$80-120M FY26E (~55% rev) 🟢 scaling into beta 60+ MNO partners incl. AT&T, Verizon, Vodafone, Rakuten, stc, Bell, Telus. Rev-share model on partner subscribers who activate D2D. Beta service launches Q4 2026 CONUS; monetization H1 2027. US Government ~$50-70M FY26E (~30% rev) 🟢 $125M+ awards signed Multiple US Government awards >$125M (DoD, FirstNet-adjacent, mission-critical federal comms). Pipeline includes additional classified / unclassified orders. Non-dilutive, higher-margin revenue stream. Gateway + Integration ~$30-50M FY26E (~15% rev) 🟡 one-time + recurring mix Ground gateway installations (~50 at various stages) and MNO network integration fees. Mostly one-time with recurring maintenance tail. Japan J-LEO via Rakuten preliminary selection could add up to $1B non-dilutive capital.
Starlink D2D competitive context: SpaceX's Direct-to-Cell service (via T-Mobile US exclusively, limited by current Gen 2 small-sat capacity) is the primary rival. ASTS's advantages: (1) larger antenna aperture per satellite enabling true broadband (not just SMS), (2) partnership breadth (60+ MNOs vs Starlink's T-Mobile exclusive), (3) licensed MNO spectrum rights. Starlink's advantages: launch cadence, vertical integration, and SpaceX balance sheet. The race is to critical mass before 2028.
Legal, regulatory and risk analysis
SWOT analysis
- +13 BlueBirds operational — only space-based D2D broadband platform at this scale
- +60+ MNO partnerships representing 3B+ addressable subscribers
- +$3.7B pro forma cash provides 6-8 quarters of runway
- +$1.3B backlog vs $175M FY26 guide = 7.4x revenue coverage
- +Large-antenna architecture enables true broadband (not just SMS) differentiation
- −Pre-profitability with $850M FY26E net loss — profitability not expected before FY28-29
- −LT debt $2.96B + $1.15B conv notes = $4.1B total — high absolute leverage
- −Share count +33% YoY; shelf registration still active for continued raises
- −High short interest 15.65% signals persistent valuation skepticism
- −Beta service still not live — commercial scaling thesis unproven
- →J-LEO Japan: up to $1B non-dilutive government capital (via Rakuten JV)
- →US JV with AT&T + Verizon preliminary — potential platform-scale deal
- →Mid-band spectrum (100 MHz) commercial starting early 2027
- →Government awards pipeline (DoD, FirstNet-adjacent) with non-dilutive revenue
- →D2D TAM — if 1% of 3B partner subs activate, $5-10B revenue steady-state
- !Starlink Direct-to-Cell commercial scale with T-Mobile US exclusive
- !Class action overhang + possible SEC inquiry escalation
- !Satellite loss events (involuntary conversion loss $125.9M in Q2) — insurance partial
- !Capex overruns delay ROIC crossover beyond FY29
- !Spectrum allocation / FCC rulemaking slips disrupt mid-band timeline
Summary by assessment area
- 13 BlueBirds in orbit, 45 target by early 2027
- 60+ MNO partners, 3B+ subscribers addressable
- Beta service launch Q4 2026 CONUS
- $1.3B backlog, FY26 guide $150-200M
- LT debt $4.1B total; short interest 15.65%
- Share count +33% YoY — continuing issuance
- Class action filed (Pomerantz); settlement $100-300M midcase
- Additional $1.5-2.5B capital likely before FCF positive
- 120x fw EV/Rev FY26 vs peer median 5x
- Base FV $52 ≈ current $56.93 (fair-ish)
- Scenario range $20-$130 reflects binary 2027 execution
- Starlink competitive discount embedded
Sources: SEC Form 8-K Q2 2026 earnings release / Nasdaq Q2 call highlights / Pomerantz LLP class action notice / rgrdlaw / Yahoo Finance / chartrow.com / Equibles FINRA short interest / Simply Wall St / Benzinga analyst ratings / Barchart. Market data — last verified close 2026-10-08: ASTS ~$56.93 (-6.13% that day), market cap ~$22.15B, 52W: $49.31–$133.86 (near 52W low), shares outstanding ~389M (post-July $1.15B conv). Short interest: 15.65% (45.8M shares, DTC 3.41, Mar 13, 2026 — pre-July dilution baseline). Cash pro forma $3.7B (incl. $1.15B conv note proceeds Jul 2026), LT debt $2.96B + $1.15B conv notes = $4.11B total. FY26 revenue guide: $150-200M; backlog $1.3B. 13/45 BlueBirds in orbit; beta service CONUS targeted Q4 2026. Class action: Pomerantz LLP (filed), rgrdlaw investigation. This document is for informational purposes only and does not constitute financial or investment advice.